Search

everythinglearnresearchcommunity

for

Search:↓

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Congenital Adrenal Hyperplasia is mainly caused by enzyme deficiencies, leading to varying symptoms like hormone imbalances and physical changes.

A new method accurately measures nine steroid hormones in human serum with high sensitivity.

New compounds may help treat prostate issues without affecting androgen receptors.

The compound was successfully made and shows potential for treating prostate cancer.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Targeting impaired Nrf2 signaling might help treat hidradenitis suppurativa early on.

Androgens don't directly affect hair cell growth or protein production.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

A new compound effectively inhibits human 5α-reductase 1.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

An over-the-counter vitamin/mineral supplement improved hair loss and blood sugar control in a woman with non-classic 11-hydroxylase deficiency.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.